docProstate Cancer Radiotherapy: Benefits of Dose
download 
Report Transcription
Prostate Cancer Radiotherapy: Benefits of Dose-Escalation PCCN: W-W welcomes you to attend our next session with Guest Speaker Robert Stephens Rob will speak about his findings of the benefits that dose-escalated radiotherapy offers men with Prostate Cancer DATE: Rob is currently a candidate for a Master of Tuesday April 28, 2015 Science degree at the University of Waterloo. He works in Dr. Spafford’s lab studying TIME: calcium channel physiology. Formerly, worked 7:00PM – 8:30PM in the Clinical Trials Department at Grand River Regional Cancer Centre, and as a student LOCATION: volunteer assisting in prostate cancer research HopeSpring Cancer with Dr. Gopaul. Support 16 Andrew St. This FREE presentation is open to ALL Kitchener, ON For Further Information or RSVP - Contact: PCCN:W-W Answering Service: 226-240-9264 Email: info@pccn-waterloo-wellington.ca Website: http://pccn-waterloo-wellington.ca Rob Stephens
Similar documents
Can Frequent Male Seed Release Really Prevent Prostate Cancer - A Look at the Facts
Manual Gratification and Prostate Health - Could This Be the Link to Fighting Prostate Cancer
Prostate Cancer - Global Drug Forecast and Market Analysis to 2023 for the $8.2 Billion Market
Prostate cancer market was valued at $2.6 billion in 2013 and it is expected to reach $8.3 million, by 2023. It is estimated that the market will grow at a CAGR of 12.4%. This growth will be driven by the label extensions of currently marketed drugs as well as the launch of nine new premium-priced therapies for the treatment of prostate cancer.
Hormone Sensitive Prostate Cancer Market Segments, Opportunity, Growth and Forecast by End-use Industry 2016-2026
Prostate cancer is a general term used for diseased condition in which abnormal cells grow and invade in uncontrolled manner in the prostate. Prostate cancer inhibits production of male sex hormones (i.e. androgens) and ultimately blocks the action of androgen. The androgen is also responsible for the growth of prostate cancer. Androgen binds with the receptors and stimulates the expression of specific genes that would be responsible for prostate cancer. However, androgen suppression hormonal therapies are commonly used for the treatment of this cancer. These therapies acts by reducing the production of androgen by the testicles or by blocking the action of androgen in the body. There is an opportunity for the growth of hormone sensitive prostate cancer owing to the rapidly aging population which is the major cause of prostate cancer.
